Prevalence of hereditary hemochromatosis in a Massachusetts Corporation: Is Celtic origin a risk factor?

Hepatology

Volumn 25, Issue 6, 1997, Pages 1439-1446

  Smith, Benjamin N ^a   Kantrowitz, Warren ^b   Grace, Norman D ^a,d   Greenberg, Mortimer S ^b   Patton, Tara J ^a   Ookubo, Rie ^a   Sorger, Karl ^c   Semeraro, John G ^b   Dovle, John R ^b   Cooper, Amiel G ^a   Kamat, Brinda R ^c   Maregni, Lucille M ^b   Rand, William M ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b POLAROID CORPORATION   (United States)

^c MOUNT AUBURN HOSPITAL   (United States)

^d Brigham and Women's/Faulkner Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; COST BENEFIT ANALYSIS; DIAGNOSTIC VALUE; HEMOCHROMATOSIS; HLA TYPING; HOMOZYGOSITY; HUMAN; INHERITANCE; IRON BLOOD LEVEL; LIVER BIOPSY; MALE; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; RISK ASSESSMENT; RISK FACTOR; SCREENING TEST; TRANSFERRIN BLOOD LEVEL;

ADULT; AGE DISTRIBUTION; CONTINENTAL POPULATION GROUPS; ETHNIC GROUPS; GREAT BRITAIN; HEALTH CARE COSTS; HEMOCHROMATOSIS; HUMANS; IRELAND; MALE; MASS SCREENING; MASSACHUSETTS; MIDDLE AGED; OCCUPATIONAL MEDICINE; PREVALENCE;

EID: 0030963287     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510250622     Document Type: Article

References (16)

1. Niederau C, Fischer R, Sonnenberg A, Stremmel W, Trampisch HJ, Strohmeyer G. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. N Engl J Med 1985;313:1256-1262.
2. Adams PC, Speechley M, Kertesz AE. Long-term survival analysis in hereditary hemochromatosis. Gastroenterology 1991;101:368-372.
3. Grace ND. Iron metabolism and hemochromatosis. In: Zakim E, Boyer TD, eds. Hepatology: A Textbook of Liver Disease. Philadelphia, PA: Saunders, 1982:1159-1176.
4. Dadone MM, Kushner JP, Edwards CQ, Bishop DT, Skolnick MH. Hereditary hemochromatosis: analysis of laboratory expression of the disease by genotype in 18 pedigrees. Am J Clin Pathol 1982;78:196-207.
5. Edwards CQ, Dadone MM, Skolnick MH, Kushner JP. Hereditary haemochromatosis. Clin Haematol 1982;11:411-435.
6. Edwards CQ. Early detection of hereditary hemochromatosis. Ann Intern Med 1984;101:707-708.
7. Bothwell TH, Charlton RW, Motulsky AG. Idiopathic hemochromatosis. In: Stanbury JB, Wyngaarden JW, Fredrickson DS, Goldstein JL, Brown MS, eds. The Metabolic Basis of Inherited Disease. 5th ed. New York: McGraw-Hill, 1983:1269-1298.
8. Borwein ST, Ghent CN, Flanagan PR, Chamberlain MJ, Valberg LS. Genetic and phenotypic expression of hemochromatosis in Canadians. Clin Invest Med 1983;6:171-179.
9. Olsson KS, Ritter B, Rosén U, Heedman PA, Staugård F. Prevalence of iron overload in central Sweden. Acta Med Scand 1983;213:145-150.
10. Lindmark B, Eriksson S. Regional differences in the idiopathic hemochromatosis gene frequency in Sweden. Acta Med Scand 1985;218:299-304.
11. Hallberg L, Björn-Rasmussen E, Jungner I. Prevalence of hereditary haemochromatosis in two Swedish urban areas. J Intern Med 1989;225:249-255.
12. Olsson KS, Eriksson K, Ritter B, Heedman PA. Screening for iron overload using transferrin saturation. Acta Med Scand 1984;215:105-112.
13. Karlsson M, Ikkala E, Reunanen A, Takkunen H, Vuori E, Mäkinen J. Prevalence of hemochromatosis in Finland. Acta Med Scand 1988;224:385-390.
14. Edwards CQ, Griffen LM, Goldgar D, Drummond C, Skolnick MH, Kushner JP. Prevalence of hemochromatosis among 11,065 presumably healthy blood donors. N Engl J Med 1988;318:1355-1362.
15. Leggett BA, Halliday JW, Brown NN, Bryant S, Powell LW. Prevalence of haemochromatosis amongst asymptomatic Australians. Br J Haematol 1990;74:525-530.
16. Velati C, Piperno A, Fargion S, Colombo S, Fiorelli G. Prevalence of idiopathic hemochromatosis in Italy: study of 1301 blood donors. Haematologica 1990;75:309-312.